Tubacin prevents neuronal migration defects and epileptic activity caused by rat Srpx2 silencing in utero

Brain

Volumn 136, Issue 8, 2013, Pages 2457-2473

  Salmi, Manal ^a,b,c   Bruneau, Nadine ^a,b,c   Cillario, Jennifer ^a,b,c   Lozovaya, Natalia ^a,b,c   Massacrier, Annick ^a,b,c   Buhler, Emmanuelle ^a,b,c   Cloarec, Robin ^a,b,c   Tsintsadze, Timur ^a,b,c   Watrin, Françoise ^a,b,c   Tsintsadze, Vera ^a,b,c   Zimmer, Céline ^c,d   Villard, Claude ^c,e   Lafitte, Daniel ^c,e   Cardoso, Carlos ^a,b,c   Bao, Lan ^f,j   Lesca, Gaetan ^b,g,h   Rudolf, Gabrielle ^b,i   Muscatelli, Françoise ^a,b,c   Pauly, Vanessa ^j   Khalilov, Ilgam ^a,b,c   Durbec, Pascale ^c,d   Ben Ari, Yehezkel ^a,b,c   Burnashev, Nail ^a,b,c   Represa, Alfonso ^a,b,c   Szepetowski, Pierre ^a,b,c   more..

^a INSERM   (France)

^b Turing Center for Living Systems CENTURI Aix Marseille University   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d AIX MARSEILLE UNIVERSITÉ   (France)

^e University of the Mediterranean Aix Marseille II   (France)

^f INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^g LYON NEUROSCIENCE RESEARCH CENTER   (France)

^h University of Lyon   (France)

ⁱ UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^j HÔPITAL SAINTE MARGUERITE   (France)

more..

Author keywords

Developmental epilepsy; In utero prevention; Neuronal migration; Srpx2; Tubulin acetylation

Indexed keywords

ALPHA TUBULIN; BIOLOGICAL MARKER; OLIGONUCLEOTIDE; SHORT HAIRPIN RNA; SUSHI REPEAT CONTAINING PROTEIN X LINKED 2; TUBACIN; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; CELL CULTURE; CONTROLLED STUDY; ELECTROPORATION; EMBRYO; EPILEPTIC DISCHARGE; EX VIVO STUDY; GENE SILENCING; GENETIC ANALYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MISSENSE MUTATION; NEURONAL MIGRATION DISORDER; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROLANDIC EPILEPSY; TONIC CLONIC SEIZURE; WILD TYPE;

EID: 84880955100     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt161     Document Type: Article

References (72)

1. Ackman JB, Aniksztejn L, Crepel V, Becq H, Pellegrino C, Cardoso C, et al. Abnormal network activity in a targeted genetic model of human double cortex. J Neurosci 2009; 29: 313-27.
2. Akella JS, Wloga D, Kim J, Starostina NG, Lyons-Abbott S, Morrissette NS, et al. MEC-17 is an alpha-tubulin acetyltransferase. Nature 2010; 467: 218-22.
3. Andrade DM. Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain. Hum Genet 2009; 126: 173-93.
4. Bai J, Ramos RL, Ackman JB, Thomas AM, Lee RV, LoTurco JJ. RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat Neurosci 2003; 6: 1277-83.
5. Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. A developmental and genetic classification for malformations of cortical development: update 2012. Brain 2012; 135: 1348-69.
6. Ben-Ari Y. Neuro-archaeology: pre-symptomatic architecture and signature of neurological disorders. Trends Neurosci 2008; 31: 626-36.
7. Bianchi DW. From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges. Nat Med 2012; 18: 1041-51.
8. Biermann B, Ivankova-Susankova K, Bradaia A, Abdel Aziz S, Besseyrias V, Kapfhammer JP, et al. The Sushi domains of GABAB receptors function as axonal targeting signals. J Neurosci 2010; 30: 1385-94.
9. Bruneau N, Nganga A, Fisher EA, Lombardo D. O-Glycosylation of Cterminal tandem-repeated sequences regulates the secretion of rat pancreatic bile salt-dependent lipase. J Biol Chem 1997; 272: 27353-61.
10. Bruneau N, Szepetowski P. The role of the urokinase receptor in epilepsy, in disorders of language, cognition, communication and behavior, and in the central nervous system. Curr Pharm Des 2011; 17: 1914-23.
11. Carabalona A, Beguin S, Pallesi-Pocachard E, Buhler E, Pellegrino C, Arnaud K, et al. A glial origin for periventricular nodular heterotopia caused by impaired expression of Filamin-A. Hum Mol Genet 2012; 21: 1004-17.
12. Carulli D, Laabs T, Geller HM, Fawcett JW. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr Opin Neurobiol 2005; 15: 116-20.
13. Cheng PL, Song AH, Wong YH, Wang S, Zhang X, Poo MM. Self-amplifying autocrine actions of BDNF in axon development. Proc Natl Acad Sci USA 2011; 108: 18430-5.
14. Creppe C, Malinouskaya L, Volvert ML, Gillard M, Close P, Malaise O, et al. Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin. Cell 2009; 136: 551-64.
15. D'Mello V, Singh S, Wu Y, Birge RB. The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells. J Biol Chem 2009; 284: 17030-8.
16. d'Ydewalle C, Krishnan J, Chiheb DM, Van Damme P, Irobi J, Kozikowski AP, et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med 2011; 17: 968-74.
17. de Nijs L, Leon C, Nguyen L, Loturco JJ, Delgado-Escueta AV, Grisar T, et al. EFHC1 interacts with microtubules to regulate cell division and cortical development. Nat Neurosci 2009; 12: 1266-74.
18. Elias LA, Wang DD, Kriegstein AR. Gap junction adhesion is necessary for radial migration in the neocortex. Nature 2007; 448: 901-7.
19. Gelisse P, Corda D, Raybaud C, Dravet C, Bureau M, Genton P. Abnormal neuroimaging in patients with benign epilepsy with centrotemporal spikes. Epilepsia 2003; 44: 372-8.
20. Gendrel M, Rapti G, Richmond JE, Bessereau JL. A secreted complementcontrol-related protein ensures acetylcholine receptor clustering. Nature 2009; 461: 992-6.
21. Giorda R, Bonaglia MC, Beri S, Fichera M, Novara F, Magini P, et al. Complex segmental duplications mediate a recurrent dup(X)(p11.22-p11.23) associated with mental retardation, speech delay, and EEG anomalies in males and females. Am J Hum Genet 2009; 85: 394-400.
22. Glenn OA, Barkovich J. Magnetic resonance imaging of the fetal brain and spine: an increasingly important tool in prenatal diagnosis: part 2. Am J Neuroradiol 2006; 27: 1807-14.
23. Guerrini R, Dobyns WB, Barkovich AJ. Abnormal development of the human cerebral cortex: genetics, functional consequences and treatment options. Trends Neurosci 2008; 31: 154-62.
24. Gunnersen JM, Kim MH, Fuller SJ, De Silva M, Britto JM, Hammond VE, et al. Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons. Neuron 2007; 56: 621-39.
25. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 2003; 100: 4389-94.
26. Heng JI, Chariot A, Nguyen L. Molecular layers underlying cytoskeletal remodelling during cortical development. Trends Neurosci 2009; 33: 38-47.
27. Heng JI, Nguyen L, Castro DS, Zimmer C, Wildner H, Armant O, et al. Neurogenin 2 controls cortical neuron migration through regulation of Rnd2. Nature 2008; 455: 114-8.
28. Jaglin XH, Chelly J. Tubulin-related cortical dysgeneses: microtubule dysfunction underlying neuronal migration defects. Trends Genet 2009; 25: 555-66.
29. Jaglin XH, Poirier K, Saillour Y, Buhler E, Tian G, Bahi-Buisson N, et al. Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria. Nat Genet 2009; 41: 746-52.
30. Jansen A, Andermann E. Genetics of the polymicrogyria syndromes. J Med Genet 2005; 42: 369-78.
31. Kazantsev AG, Thompson LM. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 2008; 7: 854-68.
32. Keays DA, Tian G, Poirier K, Huang GJ, Siebold C, Cleak J, et al. Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell 2007; 128: 45-57.
33. Kriegstein AR. Constructing circuits: neurogenesis and migration in the developing neocortex. Epilepsia 2005; 46 (Suppl 7): 15-21.
34. Kumar RA, Pilz DT, Babatz TD, Cushion TD, Harvey K, Topf M, et al. TUBA1A mutations cause wide spectrum lissencephaly (smooth brain) and suggest that multiple neuronal migration pathways converge on alpha tubulins. Hum Mol Genet 2010; 19: 2817-27.
35. Li A, Saito M, Chuang JZ, Tseng YY, Dedesma C, Tomizawa K, et al. Ciliary transition zone activation of phosphorylated Tctex-1 controls ciliary resorption, S-phase entry and fate of neural progenitors. Nat Cell Biol 2011; 13: 402-11.
36. Li L, Wei D, Wang Q, Pan J, Liu R, Zhang X, et al. MEC-17 deficiency leads to reduced alpha-tubulin acetylation and impaired migration of cortical neurons. J Neurosci 2012; 32: 12673-83.
37. Lui JH, Hansen DV, Kriegstein AR. Development and evolution of the human neocortex. Cell 2011; 146: 18-36.
38. Lundberg S, Eeg-Olofsson O, Raininko R, Eeg-Olofsson KE. Hippocampal asymmetries and white matter abnormalities on MRI in benign childhood epilepsy with centrotemporal spikes. Epilepsia 1999; 40: 1808-15.
39. Manent JB, LoTurco J. Reversing disorders of neuronal migration and differentiation in animal models. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies. 4th edn. Bethesda, MD: National Center for Biotechnology Information; 2012.
40. Manent JB, Wang Y, Chang Y, Paramasivam M, LoTurco JJ. Dcx reexpression reduces subcortical band heterotopia and seizure threshold in an animal model of neuronal migration disorder. Nat Med 2009; 15: 84-90.
41. Manzini MC, Walsh CA. What disorders of cortical development tell us about the cortex: one plus one does not always make two. Curr Opin Genet Dev 2011; 21: 333-9.
42. Marin O, Rubenstein JL. Cell migration in the forebrain. Annu Rev Neurosci 2003; 26: 441-83.
43. Miljkovic-Licina M, Hammel P, Garrido-Urbani S, Bradfield PF, Szepetowski P, Imhof BA. Sushi repeat protein X-linked 2, a novel mediator of angiogenesis. FASEB J 2009; 23: 4105-16.
44. Palazzo AF, Eng CH, Schlaepfer DD, Marcantonio EE, Gundersen GG. Localized stabilization of microtubules by integrin-and FAK-facilitated Rho signaling. Science 2004; 303: 836-9.
45. Paracchini S, Thomas A, Castro S, Lai C, Paramasivam M, Wang Y, et al. The chromosome 6p22 haplotype associated with dyslexia reduces the expression of KIAA0319, a novel gene involved in neuronal migration. Hum Mol Genet 2006; 15: 1659-66.
46. Pardoe HR, Berg AT, Archer JS, Fulbright RK, Jackson GD. A neurodevelopmental basis for BECTS: Evidence from structural MRI. Epilepsy Res 2013; pii: S0920-1211(13)00010-7. doi: 10.1016/j.eplepsyres. 2012.11.008.
47. Pereira S, Massacrier A, Roll P, Verine A, Etienne-Grimaldi MC, Poitelon Y, et al. Nuclear localization of a novel human syntaxin 1B isoform. Gene 2008; 423: 160-71.
48. Ramos RL, Bai J, LoTurco JJ. Heterotopia formation in rat but not mouse neocortex after RNA interference knockdown of DCX. Cereb Cortex 2006; 16: 1323-31.
49. Roll P, Rudolf G, Pereira S, Royer B, Scheffer IE, Massacrier A, et al. SRPX2 mutations in disorders of language cortex and cognition. Hum Mol Genet 2006; 15: 1195-207.
50. Roll P, Vernes SC, Bruneau N, Cillario J, Ponsole-Lenfant M, Massacrier A, et al. Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex. Hum Mol Genet 2010; 19: 4848-60.
51. Royer-Zemmour B, Ponsole-Lenfant M, Gara H, Roll P, Leveque C, Massacrier A, et al. Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR. Hum Mol Genet 2008; 17: 3617-30.
52. Rubenstein JL. Annual research review: development of the cerebral cortex: implications for neurodevelopmental disorders. J Child Psychol Psychiatry 2011; 52: 339-55.
53. Rubenstein JL, Rakic P. Genetic control of cortical development. Cereb Cortex 1999; 9: 521-3.
54. Rudolf G, Valenti MP, Hirsch E, Szepetowski P. From rolandic epilepsy to continuous spike-and-waves during sleep and Landau-Kleffner syndromes: insights into possible genetic factors. Epilepsia 2009; 50 (Suppl 7): 25-8.
55. Schemies J, Sippl W, Jung M. Histone deacetylase inhibitors that target tubulin. Cancer Lett 2009; 280: 222-32.
56. Sessa A, Mao CA, Colasante G, Nini A, Klein WH, Broccoli V. Tbr2-positive intermediate (basal) neuronal progenitors safeguard cerebral cortex expansion by controlling amplification of pallial glutamatergic neurons and attraction of subpallial GABAergic interneurons. Genes Dev 2010; 24: 1816-26.
57. Strug LJ, Clarke T, Chiang T, Chien M, Baskurt Z, Li W, et al. Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4). Eur J Hum Genet 2009; 17: 1171-81.
58. Studholme C. Mapping fetal brain development in utero using magnetic resonance imaging: the Big Bang of brain mapping. Annu Rev Biomed Eng 2011; 13: 345-68.
59. Sudo H, Baas PW. Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts. J Neurosci 2010; 30: 7215-26.
60. Tanaka K, Arao T, Maegawa M, Matsumoto K, Kaneda H, Kudo K, et al. SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion. Int J Cancer 2009; 124: 1072-80.
61. Tanaka K, Arao T, Tamura D, Aomatsu K, Furuta K, Matsumoto K, et al. SRPX2 is a novel chondroitin sulfate proteoglycan that is overexpressed in gastrointestinal cancer. PLoS One 2012; 7: e27922.
62. Tang H, Kerins DM, Hao Q, Inagami T, Vaughan DE. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J Biol Chem 1998; 273: 18268-72.
63. Valenzuela-Fernandez A, Cabrero JR, Serrador JM, Sanchez-Madrid F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol 2008; 18: 291-7.
64. Valiente M, Marin O. Neuronal migration mechanisms in development and disease. Curr Opin Neurobiol 2010; 20: 68-78.
65. Velisek L, Kubova H, Pohl M, Stankova L, Mares P, Schickerova R. Pentylenetetrazol-induced seizures in rats: an ontogenetic study. Naunyn Schmiedebergs Arch Pharmacol 1992; 346: 588-91.
66. Wynshaw-Boris A, Pramparo T, Youn YH, Hirotsune S. Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. Semin Cell Dev Biol 2010; 21: 823-30.
67. Yamada M, Yoshida Y, Mori D, Takitoh T, Kengaku M, Umeshima H, et al. Inhibition of calpain increases LIS1 expression and partially rescues in vivo phenotypes in a mouse model of lissencephaly. Nat Med 2009; 15: 1202-7.
68. Yassin L, Benedetti BL, Jouhanneau JS, Wen JA, Poulet JF, Barth AL. An embedded subnetwork of highly active neurons in the neocortex. Neuron 2010; 68: 1043-50.
69. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of shortinterfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002; 99: 6047-52.
70. Zhang Y, Kwon S, Yamaguchi T, Cubizolles F, Rousseaux S, Kneissel M, et al. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol 2008; 28: 1688-701.
71. Zhou Q, Gallo JM. Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography-electrospray ionization-tandem mass spectrometry and pharmacokinetic application. J Pharm Biomed Anal 2010; 51: 958-64.
72. Zilberman Y, Ballestrem C, Carramusa L, Mazitschek R, Khochbin S, Bershadsky A. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci 2009; 122: 3531-41. Médicale